AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Ruprazole Injection

Prescription Icon
Prescription Required

Marketer

Ajuras Pharmaceutical Pvt Ltd

Salt Composition

Pantoprazole (40mg)

Overview Ruprazole Injection

Gastric acid secretion is diminished by the intravenous administration of Injex, a proton pump inhibitor (PPI). Indicated for acid-related gastrointestinal disorders including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, Injex relieves symptoms and facilitates healing. Prophylactic use is also indicated in critically ill patients to prevent stress ulcers and pre-anesthesia to mitigate aspiration risks. Injex is administered intravenously by a healthcare provider only when deemed clinically preferable to oral medication. Dosage and treatment duration are determined by your physician based on your individual response and condition; consistent adherence to the prescribed regimen is crucial, even with rapid symptom resolution. Dietary modifications, such as frequent small meals and avoidance of caffeine, spicy foods, and fatty meals, can enhance treatment efficacy. Common, generally mild, adverse events include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome side effects warrant medical consultation. Prolonged use, particularly exceeding one year or at higher doses, may elevate the risk of bone fractures. Discuss bone health strategies with your doctor, such as calcium and vitamin D supplementation. Prior to Injex administration, inform your physician of any severe hepatic impairment, concomitant HIV medication use, prior allergic reactions to PPIs, pre-existing osteoporosis, or pregnancy/breastfeeding. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.

Uses of Ruprazole Injection

Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Ruprazole Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Ruprazole Injection:

  • Diarrhea
  • Flatulence
  • Headache
  • Joint pain
  • Nausea
  • Stomach pain
  • Vomiting
  • Dizziness
  • Thrombophlebitis

How to use Ruprazole Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Ruprazole Injection works:

Acid reflux and indigestion find relief with Ruprazole Injection, a proton pump inhibitor (PPI) that diminishes stomach acid production.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Ruprazole Injection is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ruprazole Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administering Ruprazole Injection while breastfeeding appears unlikely to pose a substantial risk. Available data from human studies indicate minimal danger to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Ruprazole Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Patients with renal impairment can safely receive Ruprazole Injection without requiring any modification to the prescribed dosage.

LiverLiverCAUTION

Patients with significant hepatic impairment should receive Ruprazole Injection with close monitoring. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Ruprazole Injection :

Omit a Ruprazole Injection dose? Seek your physician's advice.

Facts to Know About Ruprazole Injection

LabelValue
Type of Compound Benzimidazole-sulfonyl compound
Addiction potential None.
Medication Classification Digestive system
Mechanism of Action Gastric acid secretion suppressants

FAQs on Ruprazole Injection

Ruprazole Injection treats peptic ulcers, reflux esophagitis, and gastroesophageal reflux disease (GERD). It counteracts the acidity often caused by pain relievers. This injection also manages Zollinger-Ellison syndrome (ZES), a condition involving excessive stomach acid. Its mechanism involves decreasing stomach acid production, thereby alleviating symptoms.
Concurrent use of antacids and Ruprazole Injection is permissible. Administer antacids at least two hours before or after the Ruprazole Injection.
Noticeable improvement should occur within 2–3 days. However, Ruprazole Injection may require up to four weeks to achieve full effectiveness; some symptoms might persist until then.
Prolonged Ruprazole Injection therapy, while uncommon, can lead to weight increase. This may be attributed to improved reflux symptoms resulting in increased food intake. Address any weight concerns with your physician.
Consuming alcohol while using Ruprazole Injection is discouraged. While alcohol doesn't directly interfere with Ruprazole's mechanism, it can stimulate excess stomach acid, potentially exacerbating your condition.
Administer Ruprazole Injection one hour prior to eating. Consuming spicy or greasy foods should be avoided during treatment. Refrain from beverages containing caffeine, including tea, coffee, and cola. Similarly, alcohol should be omitted, as it can exacerbate existing symptoms.
Ruprazole Injection is typically administered for brief periods. Extended treatment, though possible for conditions like peptic ulcer disease and Zollinger-Ellison syndrome, increases the potential for adverse reactions and necessitates ongoing medical oversight. Patients should strictly adhere to their physician's instructions and remain under their care throughout the treatment course.
Concurrent use of analgesics and Ruprazole Injection is considered safe. Ruprazole Injection offers protection against the gastric irritation and ulceration sometimes caused by painkillers. Ruprazole Injection should be administered one hour prior to meals, while analgesics are typically best consumed with or following a meal to minimize gastrointestinal discomfort.
A single dose of Ruprazole Injection may prove inadequate. Symptom relief is often achieved with just a few doses. Generally, Ruprazole Injection is used short-term, up to two weeks, for conditions like heartburn, indigestion, and acid reflux. Longer-term use might be necessary, however, for treating peptic ulcer disease or Zollinger-Ellison syndrome (ZES), as determined by your physician. If symptoms persist after two weeks of regular use as directed, consult your doctor.
Prolonged Ruprazole Injection use beyond three months can induce several adverse effects. Hypomagnesemia, a notable consequence, manifests as fatigue, confusion, dizziness, tremor, or unsteady gait. Muscle spasms and arrhythmias may also occur. Extended administration exceeding one year elevates the risk of bone fractures, gastrointestinal infections, and vitamin B12 deficiency. This deficiency can cause anemia, leading to increased fatigue, weakness, pallor, palpitations, dyspnea, lightheadedness, dyspepsia, anorexia, flatulence, and neurological symptoms including paresthesia and gait disturbances.
Ruprazole Injection
38
MRP 47
18% off